Violations highlight growing concerns over the unchecked rise in medicine prices and their impact on affordability ...

The company isn't content with just one area of focus; it's actively expanding into new verticals like injectables, peptides, ...

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.

Telangana: Apitoria Pharma Private Limited, a wholly owned subsidiary of Aurobindo Pharma, has received an Establishment ...

Curateq Biologics, a wholly owned subsidiary of Aurobindo Pharma, has allotted 4,125,055 Compulsory Convertible Preference Shares (CCPSs) of Rs.10/- each to Dr. Satakarni Makkapati on 20 March 2025.

Hyderabad: Nearly a year and a half after its subsidiary, Auro Vaccines Pvt Ltd, inked a licensing pact with Hilleman ...

On March 13, 2025, the Federal Circuit decided in Merck Sharp & Dohme B.V. v. Aurobindo Pharma USA, Inc. (No. 2023-2254) how ...

Aurobindo Pharma rose 1.82% to Rs 1,157.90 after its subsidiary, Apitoria Pharma, received an establishment inspection report (EIR) from the U.S. Food and Drug Administration for its active ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Aurobindo Pharma Ltd share price was up by 2.36% from the previous closing price of ₹1,137.00. Who are peers of Aurobindo Pharma Ltd? The peers of Aurobindo Pharma Ltd are Sun Pharmaceuticals ...